Measurement of lipoprotein subclass profiles by nuclear magnetic resonance spectroscopy

Clinical Laboratory

Volumn 48, Issue 3-4, 2002, Pages 171-180

  Otvos, James D ^a  

^a LIPOSCIENCE INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; VERY LOW DENSITY LIPOPROTEIN;

ANALYTIC METHOD; ARTICLE; ATHEROGENESIS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; HUMAN; ISCHEMIC HEART DISEASE; LIPID ANALYSIS; LIPOPROTEIN METABOLISM; MEASUREMENT; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PARTICLE SIZE; PROTEIN ANALYSIS; RISK ASSESSMENT; RISK FACTOR; RISK MANAGEMENT;

AUTOMATIC DATA PROCESSING; HUMANS; HYPERLIPIDEMIAS; LIPOPROTEINS; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; RISK ASSESSMENT;

EID: 0036210564     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Incidence of coronary heart disease and lipoprotein cholesterol levels: The Framingham Study
2. Plasma triglyceride and coronary heart disease
3. Lipoprotein subspecies and risk of coronary disease
4. Relation of lipoprotein subclasses as measured by proton nuclear magnetic resonance spectroscopy to coronary artery disease
5. Lipoproteins and atherogenesis: Current concepts
6. Low-density lipoprotein subclass patterns and risk of myocardial infarction
7. Role of plasma triglyceride in the regulation of plasma low-density lipoprotein (LDL) subfractions: Relative contribution of small, dense LDL to coronary heart disease risk
8. Low-density particle size and coronary artery disease
9. Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women
10. A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction
11. Small, dense, low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men: Prospective results from the Quebec Cardiovascular Study
12. Intermediate-density lipoproteins and progression of carotid arterial wall intima-media thickness
13. Alterations in the concentration of an apolipoprotein-E-containing subfraction of plasma high-density lipoprotein in coronary heart disease
14. High-density lipoproteins and coronary atherosclerosis: A strong inverse relation with the largest particles is confined to normotriglyceridemic patients
15. Quantification of postprandial triglyceride-rich lipoproteins in healthy men by retinyl ester labeling and simultaneous measurement of apolipoproteins B-48 and B-100
16. Relation of triglyceride metabolism and coronary artery disease: Studies in the postprandial state
17. NCEP recommendations on lipoprotein measurement
18. Quantification of plasma lipoproteins by proton nuclear magnetic resonance spectroscopy
19. Development of a proton nuclear magnetic resonance spectroscopic method for determining plasma lipoprotein concentrations and subspecies distributions from a single, rapid measurement
20. Effects of orientational order and particle size on the NMR line positions of lipoproteins
21. A spectroscopic approach to lipoprotein subclass analysis
22. Electron-microscopic evidence for particles smaller than 250 A in very-low-density lipoproteins of human plasma
23. Cryopreservation with sucrose maintains normal physical and biological properties of human plasma low-density lipoproteins
24. Differences in LDL subspecies involve alterations in lipid composition and conformational changes in apolipoprotein B
25. Hepatic lipase influences high-density lipoprotein subclass distribution in normotriglyceridemic men: Genetic and pharmacological evidence
26. Putting low-density lipoproteins at center stage in atherogenesis
27. Measurement of triglyceride-rich lipoproteins by nuclear magnetic resonance spectroscopy
28. Understanding coronary heart disease as a consequence of defective regulation of apolipoprotein B metabolism
29. Plasma cholesteryl ester transfer protein
30. Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease
31. Studies of low-density lipoproteins isolated from Macaca Fascicularis fed an atherogenic diet
32. Low-density lipoprotein particle size is inversely related to plasminogen-activator inhibitor-I levels: The Insulin Resistance Atherosclerosis Study
33. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)
34. Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome